ALS (motor neurone disease): open trials in China

• NCT07082192

  A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

  Trial Treatment · Phase 2/3 · Shanghai Zhimeng Biopharma, Inc.

  Peking University Third Hospital, Beijing

  Registry updated 2026-09-22

• NCT07539662

  Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

  Trial Treatment · Institute of Hematology & Blood Diseases Hospital, China

  Institute of Hematology & Blood Diseases Hospital, Tianjin

  Registry updated 2026-04-20

• NCT07169175

  A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS

  Trial Treatment · Phase 1/2 · SineuGene Therapeutics Co., Ltd.

  Peking University Third Hospital, Beijing · Fujian Medical University Union Hospital, Fuzhou · Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

  Registry updated 2025-09-11

• NCT06849609

  A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

  Trial Treatment · Early phase 1 · Hong Chen

  Tongji Hospital, Wuhan

  Registry updated 2025-03-17

• NCT06765564

  Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)

  Trial Treatment · Shanghai East Hospital

  Shang hai East Hospital, Shanghai

  Registry updated 2025-01-09

• NCT06645197

  An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis

  Trial Treatment · Early phase 1 · Peking University Third Hospital

  Peking University Third Hospital, Beijing · West China Hospital of Sichuan University, Chengdu · Fujian Medical University Union Hospital, Fujian · Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou · JiangSu Provincce Hospital, Nanjing

  Registry updated 2024-10-16

• NCT05923905

  Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

  Trial Treatment · Phase 4 · Peking University Third Hospital

  Peking University Third Hospital, Beijing

  Registry updated 2023-11-22

All ALS (motor neurone disease) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error